Verastem Statistics
Total Valuation
Verastem has a market cap or net worth of $598.22 million. The enterprise value is $518.61 million.
Important Dates
The next estimated earnings date is Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Verastem has 61.55 million shares outstanding. The number of shares has increased by 95.02% in one year.
| Current Share Class | 61.55M |
| Shares Outstanding | 61.55M |
| Shares Change (YoY) | +95.02% |
| Shares Change (QoQ) | +36.67% |
| Owned by Insiders (%) | 0.72% |
| Owned by Institutions (%) | 64.64% |
| Float | 45.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 238.28 |
| Forward PS | 11.75 |
| PB Ratio | 16.59 |
| P/TBV Ratio | 29.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 242.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.46, with a Debt / Equity ratio of 2.35.
| Current Ratio | 3.46 |
| Quick Ratio | 3.31 |
| Debt / Equity | 2.35 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -58.03 |
Financial Efficiency
Return on equity (ROE) is -437.92% and return on invested capital (ROIC) is -96.57%.
| Return on Equity (ROE) | -437.92% |
| Return on Assets (ROA) | -64.80% |
| Return on Invested Capital (ROIC) | -96.57% |
| Return on Capital Employed (ROCE) | -107.30% |
| Revenue Per Employee | $27,397 |
| Profits Per Employee | -$2.14M |
| Employee Count | 78 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Verastem has paid $185,000 in taxes.
| Income Tax | 185,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +247.14% in the last 52 weeks. The beta is 0.92, so Verastem's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | +247.14% |
| 50-Day Moving Average | 7.17 |
| 200-Day Moving Average | 6.21 |
| Relative Strength Index (RSI) | 61.74 |
| Average Volume (20 Days) | 2,639,900 |
Short Selling Information
The latest short interest is 15.96 million, so 25.94% of the outstanding shares have been sold short.
| Short Interest | 15.96M |
| Short Previous Month | 15.96M |
| Short % of Shares Out | 25.94% |
| Short % of Float | 34.80% |
| Short Ratio (days to cover) | 5.46 |
Income Statement
In the last 12 months, Verastem had revenue of $2.14 million and -$166.56 million in losses. Loss per share was -$3.52.
| Revenue | 2.14M |
| Gross Profit | 1.82M |
| Operating Income | -156.56M |
| Pretax Income | -89.49M |
| Net Income | -166.56M |
| EBITDA | -156.41M |
| EBIT | -156.56M |
| Loss Per Share | -$3.52 |
Full Income StatementBalance Sheet
The company has $164.32 million in cash and $84.72 million in debt, giving a net cash position of $79.61 million or $1.29 per share.
| Cash & Cash Equivalents | 164.32M |
| Total Debt | 84.72M |
| Net Cash | 79.61M |
| Net Cash Per Share | $1.29 |
| Equity (Book Value) | 36.06M |
| Book Value Per Share | 0.59 |
| Working Capital | 123.91M |
Full Balance SheetCash Flow
| Operating Cash Flow | -120.23M |
| Capital Expenditures | n/a |
| Free Cash Flow | -120.23M |
| FCF Per Share | -$1.95 |
Full Cash Flow StatementMargins
| Gross Margin | 85.12% |
| Operating Margin | -7,326.11% |
| Pretax Margin | -7,785.21% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Verastem does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -95.02% |
| Shareholder Yield | -95.02% |
| Earnings Yield | -27.84% |
| FCF Yield | -20.10% |
Analyst Forecast
The average price target for Verastem is $13.38, which is 37.65% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.38 |
| Price Target Difference | 37.65% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 120.70% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 1, 2023. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jun 1, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
Verastem has an Altman Z-Score of -8.42 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.42 |
| Piotroski F-Score | 2 |
